WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN) Thursday said second-quarter net income increased to $166.5 million or $0.83 per share from $95.9 million or $0.48 per share last year.
Adjusted net income was $229.1 million, or $1.12 per share, while it totaled $147.2 million, or $0.73 per share in the prior year.
On average, 18 analysts polled by Thomson Reuters expected earnings of $1.07 per share for the quarter. Analysts' estimates typically exclude special items.
Net product sales increased 38 percent to $512.5 million from $370.1 million in 2013. Analysts expected revenues of $510.27 million.
Further, Alexion lifted its revenue guidance for 2014 from the previous range of $2.15 to $2.17 billion to a range of $2.18 to $2.20 billion.
Non-GAAP earnings per share is also being revised upward, from the previous range of $4.75 to $4.85, to a range of $4.95 to $5.05 per share.
Wall Street expects full year earnings of $4.86 per share on revenues of $2.18 billion.
Copyright RTT News/dpa-AFX